Watch MGNX. Know when insiders buy.
One email the day a filing lands. Free.
Work order
49
WATCH · insiders 44, shorts 53
Insiders, 90 days
−$129K
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $280.3MP/E —DIV YIELD —FCF YIELD -23.39%REV TTM $167.7M +11.7%NET INCOME −$14.6MNET CASH —52W 1.33 – 4.86SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $32.8M | +378.0% | — | −$13.9M | $19.5M | — | 0.31 | −$40.7M | $806K | −$41.6M | Aug 14 |
| Q1 2026 · Mar 31 | $20.8M | +57.5% | — | −$33.4M | −$36.8M | — | -0.58 | −$35.8M | $344K | −$36.2M | Aug 14 |
| Q4 2025 · Dec 31derived | $41.2M | +113.0% | 100.0% | −$12.1M | −$14.2M | — | -0.22 | $43M | $244K | $42.8M | Mar 9 |
| Q3 2025 · Sep 30 | $72.8M | −34.2% | 100.0% | $18.6M | $16.8M | −70.1% | 0.27 | −$30.2M | $426K | −$30.6M | Nov 12 |
| Q2 2025 · Jun 30 | $6.9M | −36.4% | 100.0% | −$43.2M | −$36.3M | — | -0.57 | −$47M | $715K | −$47.7M | Aug 14 |
| Q1 2025 · Mar 31 | $13.2M | +44.9% | 100.0% | −$42.6M | −$41M | — | -0.65 | −$46.9M | $529K | −$47.4M | Aug 14 |
| Q4 2024 · Dec 31derived | $19.4M | +80.5% | 98.8% | −$52.8M | −$15.4M | — | -0.25 | −$38.4M | $620K | −$39M | Mar 9 |
| Q3 2024 · Sep 30 | $110.7M | +964.8% | 99.8% | $54.2M | $56.3M | +220.8% | 0.90 | $60.2M | $592K | $59.6M | Nov 12 |
| Q2 2024 · Jun 30 | $10.8M | — | 98.4% | −$58.2M | −$55.7M | — | -0.89 | −$44.5M | $1M | −$45.5M | Nov 12 |
| Q1 2024 · Mar 31 | $9.1M | — | 97.0% | −$53.8M | −$52.2M | — | -0.84 | −$45.6M | $1.5M | −$47.1M | Nov 12 |
| Q4 2023 · Dec 31derived | $10.7M | — | 98.5% | −$49.4M | −$46.1M | — | -0.75 | −$28M | $620K | −$28.7M | Mar 9 |
| Q3 2023 · Sep 30 | $10.4M | — | 99.2% | −$35.5M | $17.6M | — | 0.28 | −$35.2M | $499K | −$35.7M | Nov 5 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $149.5M | 100.0% | −$72.8M | −$74.6M | -49.9% | -1.18 | −$81M | $1.9M | −$83M | — | — |
| FY2024 · to Dec 31 | $150M | 99.4% | −$110.6M | −$67M | -44.7% | -1.07 | −$68.4M | $3.7M | −$72.1M | — | — |
| FY2023 · to Dec 31 | $58.7M | 98.9% | −$168.2M | −$9.1M | -15.4% | -0.15 | −$78.2M | $1.8M | −$80M | — | — |
| FY2022 · to Dec 31 | $151.9M | 97.8% | −$121.4M | −$119.8M | -78.8% | -1.95 | −$87M | $3.6M | −$90.6M | — | — |
| FY2021 · to Dec 31 | $77.4M | 96.6% | −$202.8M | −$202.1M | -261.0% | -3.37 | −$143.8M | $6.2M | −$150M | — | — |
| FY2020 · to Dec 31 | $104.9M | 100.0% | −$131.1M | −$129.7M | -123.7% | -2.47 | −$111.9M | $5.9M | −$117.8M | — | — |
Every number comes from MACROGENICS INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.